ABBOTT LABORATORIES (ABL.DE) Fundamental Analysis & Valuation

FRA:ABL • US0028241000

94.08 EUR
-0.38 (-0.4%)
Last: Mar 13, 2026, 03:24 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This ABL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

ABL gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 65 industry peers in the Health Care Equipment & Supplies industry. ABL has an excellent profitability rating, but there are some minor concerns on its financial health. ABL is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. ABL.DE Profitability Analysis

1.1 Basic Checks

  • ABL had positive earnings in the past year.
  • ABL had a positive operating cash flow in the past year.
  • ABL had positive earnings in each of the past 5 years.
  • Each year in the past 5 years ABL had a positive operating cash flow.
ABL.DE Yearly Net Income VS EBIT VS OCF VS FCFABL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • With an excellent Return On Assets value of 7.52%, ABL belongs to the best of the industry, outperforming 83.08% of the companies in the same industry.
  • ABL's Return On Equity of 12.51% is fine compared to the rest of the industry. ABL outperforms 75.38% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 9.17%, ABL is in the better half of the industry, outperforming 72.31% of the companies in the same industry.
  • ABL had an Average Return On Invested Capital over the past 3 years of 8.63%. This is below the industry average of 10.72%.
  • The last Return On Invested Capital (9.17%) for ABL is above the 3 year average (8.63%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.52%
ROE 12.51%
ROIC 9.17%
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ABL.DE Yearly ROA, ROE, ROICABL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • The Profit Margin of ABL (14.72%) is better than 86.15% of its industry peers.
  • In the last couple of years the Profit Margin of ABL has grown nicely.
  • ABL's Operating Margin of 18.85% is fine compared to the rest of the industry. ABL outperforms 75.38% of its industry peers.
  • ABL's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 56.68%, ABL is in line with its industry, outperforming 47.69% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ABL has remained more or less at the same level.
Industry RankSector Rank
OM 18.85%
PM (TTM) 14.72%
GM 56.68%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
ABL.DE Yearly Profit, Operating, Gross MarginsABL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. ABL.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ABL is destroying value.
  • The number of shares outstanding for ABL has been increased compared to 1 year ago.
  • The number of shares outstanding for ABL has been reduced compared to 5 years ago.
  • ABL has a better debt/assets ratio than last year.
ABL.DE Yearly Shares OutstandingABL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
ABL.DE Yearly Total Debt VS Total AssetsABL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.2 Solvency

  • An Altman-Z score of 5.05 indicates that ABL is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 5.05, ABL belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
  • ABL has a debt to FCF ratio of 1.75. This is a very positive value and a sign of high solvency as it would only need 1.75 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 1.75, ABL is doing good in the industry, outperforming 80.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.19 indicates that ABL is not too dependend on debt financing.
  • ABL has a Debt to Equity ratio of 0.19. This is in the better half of the industry: ABL outperforms 73.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.75
Altman-Z 5.05
ROIC/WACC0.93
WACC9.83%
ABL.DE Yearly LT Debt VS Equity VS FCFABL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • A Current Ratio of 1.58 indicates that ABL should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.58, ABL is in line with its industry, outperforming 49.23% of the companies in the same industry.
  • A Quick Ratio of 1.18 indicates that ABL should not have too much problems paying its short term obligations.
  • ABL's Quick ratio of 1.18 is in line compared to the rest of the industry. ABL outperforms 52.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.18
ABL.DE Yearly Current Assets VS Current LiabilitesABL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ABL.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 10.28% over the past year.
  • Measured over the past 5 years, ABL shows a small growth in Earnings Per Share. The EPS has been growing by 7.13% on average per year.
  • The Revenue has been growing slightly by 5.67% in the past year.
  • ABL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.08% yearly.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%

3.2 Future

  • Based on estimates for the next years, ABL will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.38% on average per year.
  • The Revenue is expected to grow by 7.06% on average over the next years.
EPS Next Y11.53%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
EPS Next 5Y10.38%
Revenue Next Year7%
Revenue Next 2Y7.19%
Revenue Next 3Y7.11%
Revenue Next 5Y7.06%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ABL.DE Yearly Revenue VS EstimatesABL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
ABL.DE Yearly EPS VS EstimatesABL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. ABL.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 21.09, ABL is valued on the expensive side.
  • Based on the Price/Earnings ratio, ABL is valued a bit cheaper than 75.38% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.71. ABL is around the same levels.
  • A Price/Forward Earnings ratio of 18.91 indicates a rather expensive valuation of ABL.
  • Based on the Price/Forward Earnings ratio, ABL is valued a bit cheaper than the industry average as 61.54% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.82, ABL is valued a bit cheaper.
Industry RankSector Rank
PE 21.09
Fwd PE 18.91
ABL.DE Price Earnings VS Forward Price EarningsABL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • ABL's Enterprise Value to EBITDA ratio is in line with the industry average.
  • 61.54% of the companies in the same industry are more expensive than ABL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 25.53
EV/EBITDA 16.83
ABL.DE Per share dataABL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ABL does not grow enough to justify the current Price/Earnings ratio.
  • ABL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.83
PEG (5Y)2.96
EPS Next 2Y10.76%
EPS Next 3Y10.34%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. ABL.DE Dividend Analysis

5.1 Amount

  • ABL has a Yearly Dividend Yield of 2.27%. Purely for dividend investing, there may be better candidates out there.
  • ABL's Dividend Yield is rather good when compared to the industry average which is at 1.01. ABL pays more dividend than 83.08% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, ABL pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.27%

5.2 History

  • The dividend of ABL is nicely growing with an annual growth rate of 10.37%!
Dividend Growth(5Y)10.37%
Div Incr Years6
Div Non Decr Years6
ABL.DE Yearly Dividends per shareABL.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • ABL pays out 63.09% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of ABL is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP63.09%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
ABL.DE Yearly Income VS Free CF VS DividendABL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
ABL.DE Dividend Payout.ABL.DE Dividend Payout, showing the Payout Ratio.ABL.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ABL.DE Fundamentals: All Metrics, Ratios and Statistics

ABBOTT LABORATORIES

FRA:ABL (3/13/2026, 3:24:57 PM)

94.08

-0.38 (-0.4%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22
Earnings (Next)04-14
Inst Owners81.83%
Inst Owner ChangeN/A
Ins Owners0.47%
Ins Owner ChangeN/A
Market Cap163.48B
Revenue(TTM)44.33B
Net Income(TTM)6.52B
Analysts80
Price Target114.26 (21.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.27%
Yearly Dividend2.05
Dividend Growth(5Y)10.37%
DP63.09%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.9%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.75%
EPS beat(4)1
Avg EPS beat(4)-0.41%
Min EPS beat(4)-1.06%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.09%
EPS beat(12)6
Avg EPS beat(12)0.64%
EPS beat(16)10
Avg EPS beat(16)5.12%
Revenue beat(2)0
Avg Revenue beat(2)-2.58%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-1.29%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-1.18%
Revenue beat(12)3
Avg Revenue beat(12)-0.45%
Revenue beat(16)7
Avg Revenue beat(16)1.23%
PT rev (1m)-1.45%
PT rev (3m)-8.45%
EPS NQ rev (1m)0.04%
EPS NQ rev (3m)-4.33%
EPS NY rev (1m)0.03%
EPS NY rev (3m)0.2%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-1.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.88%
Valuation
Industry RankSector Rank
PE 21.09
Fwd PE 18.91
P/S 4.26
P/FCF 25.53
P/OCF 19.73
P/B 3.62
P/tB 8.36
EV/EBITDA 16.83
EPS(TTM)4.46
EY4.74%
EPS(NY)4.97
Fwd EY5.29%
FCF(TTM)3.69
FCFY3.92%
OCF(TTM)4.77
OCFY5.07%
SpS22.09
BVpS25.98
TBVpS11.25
PEG (NY)1.83
PEG (5Y)2.96
Graham Number51.06
Profitability
Industry RankSector Rank
ROA 7.52%
ROE 12.51%
ROCE 11.9%
ROIC 9.17%
ROICexc 10.51%
ROICexgc 20.3%
OM 18.85%
PM (TTM) 14.72%
GM 56.68%
FCFM 16.68%
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ROICexc(3y)9.83%
ROICexc(5y)11.21%
ROICexgc(3y)21.64%
ROICexgc(5y)29.96%
ROCE(3y)11.19%
ROCE(5y)12.44%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-6%
ROICexc growth 3Y-8.69%
ROICexc growth 5Y6.09%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.75
Debt/EBITDA 0.86
Cap/Depr 69.67%
Cap/Sales 4.9%
Interest Coverage 15.33
Cash Conversion 83.39%
Profit Quality 113.35%
Current Ratio 1.58
Quick Ratio 1.18
Altman-Z 5.05
F-Score6
WACC9.83%
ROIC/WACC0.93
Cap/Depr(3y)68.72%
Cap/Depr(5y)62.77%
Cap/Sales(3y)5.22%
Cap/Sales(5y)4.82%
Profit Quality(3y)83.05%
Profit Quality(5y)96.8%
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y11.53%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
EPS Next 5Y10.38%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year7%
Revenue Next 2Y7.19%
Revenue Next 3Y7.11%
Revenue Next 5Y7.06%
EBIT growth 1Y18.75%
EBIT growth 3Y-1.48%
EBIT growth 5Y8.93%
EBIT Next Year25.72%
EBIT Next 3Y14.17%
EBIT Next 5Y13.17%
FCF growth 1Y16.44%
FCF growth 3Y-1.78%
FCF growth 5Y5.26%
OCF growth 1Y11.78%
OCF growth 3Y-0.05%
OCF growth 5Y3.9%

ABBOTT LABORATORIES / ABL.DE FAQ

What is the fundamental rating for ABL stock?

ChartMill assigns a fundamental rating of 6 / 10 to ABL.DE.


Can you provide the valuation status for ABBOTT LABORATORIES?

ChartMill assigns a valuation rating of 3 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Overvalued.


What is the profitability of ABL stock?

ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for ABL stock?

The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABL.DE) is 21.09 and the Price/Book (PB) ratio is 3.62.


How sustainable is the dividend of ABBOTT LABORATORIES (ABL.DE) stock?

The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 6 / 10 and the dividend payout ratio is 63.09%.